Type III interferon (IFN-lambda) antagonizes the antiviral activity of interferon-alpha in vitro

J Biol Regul Homeost Agents. 2013 Oct-Dec;27(4):1001-9.

Abstract

Type III interferons (IFN-lambda) are the most recently discovered members of IFN family. Synergism between different IFN types is well established, but for type I and type III IFNs no conclusive evidence has been reported so far. Possible synergism/antagonism between IFN-alpha and IFN-lambda in the inhibition of virus replication (EMCV, WNV lineage 1 and 2, CHIKV and HSV-1), and in the activation of intracellular pathways of IFN response (MxA and 2'-5' OAS) was evaluated in different cell lines (Vero E6, A549 and Wish cells). The antiviral potency of IFN-lambda1 and -l2 was lower than that of IFN-alpha. When IFN-alpha and -lambda were used together, the Combination Index (CI) for virus inhibition was greater than 1 virtually for all virus/host cell systems, indicating antagonistic effect. Antagonism between IFN-alpha and -l was also observed for the induction of mRNA for both MxA and 2'-5'OAS. Elucidating the interplay between IFN-alpha and -lambda may help to better understand innate defence mechanisms against viral infections, including the molecular mechanisms underlying the influence of IL-28B polymorphisms in the response to HCV and other viral infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2',5'-Oligoadenylate Synthetase / genetics*
  • Animals
  • Antiviral Agents / antagonists & inhibitors*
  • Chlorocebus aethiops
  • Encephalomyocarditis virus / drug effects
  • Humans
  • Interferon-alpha / antagonists & inhibitors*
  • Interferons / pharmacology*
  • Interleukins / pharmacology*
  • Myxovirus Resistance Proteins / genetics
  • Vero Cells
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • interferon-lambda, human
  • Interferon-alpha
  • Interleukins
  • MX1 protein, human
  • Myxovirus Resistance Proteins
  • Interferons
  • 2',5'-Oligoadenylate Synthetase